GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
5HTK | O60825 | Human Heart 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase (PFKFB2) | |
4BSE | M4YV75 | Human H7N9 Influenza Virus Haemagglutinin in Complex with Human Receptor Analogue LSTc | |
4BSF | M4YV75 | Human H7N9 Influenza Virus Haemagglutinin in Complex with Avian Receptor Analogue 3'-SLN | |
4BSB | M4YV75 | Human H7N9 Influenza Virus Haemagglutinin (with Asn-133 Glycosylation) in Complex with Human Receptor Analogue LSTc | |
4BSC | M4YV75 | Human H7N9 Influenza Virus Haemagglutinin (with Asn-133 Glycosylation) in Complex with Human Receptor Analogue 6'-SLN | |
4BSD | M4YV75 | Human H7N9 Influenza Virus Haemagglutinin (with Asn-133 Glycosylation) in Complex with Avian Receptor Analogue 3'-SLN | |
3VLN | P78417 | Human Glutathione Transferase O1-1 C32S Mutant in Complex with Ascorbic Acid | |
4NO7 | P35557 | Human Glucokinase in complex with a nanomolar activator. | |
4MLH | P35557 | Human Glucokinase in Complex with a Novel Amino Thiazole Allosteric Activator | |
4MLE | P35557 | Human Glucokinase in Complex with Novel Amino Thiazole Activator | |
8E99 | Q05586 | Human GluN1a-GluN2A-GluN2C triheteromeric NMDA receptor in complex with Nb-4 | |
8E99 | Q12879 | Human GluN1a-GluN2A-GluN2C triheteromeric NMDA receptor in complex with Nb-4 | |
8E99 | Q14957 | Human GluN1a-GluN2A-GluN2C triheteromeric NMDA receptor in complex with Nb-4 | |
8E99 | 8E99 | Human GluN1a-GluN2A-GluN2C triheteromeric NMDA receptor in complex with Nb-4 | |
7BE3 | P17931 | Human Galectin-3 in complex with LacdiNAc | |
6K2Z | Q8TCE9 | Human Galectin-14 with lactose | |
7Q0S | P13807 | Human GYS1-GYG1 complex inhibited-like state bound to glucose-6-phosphate | |
7Q0S | P46976 | Human GYS1-GYG1 complex inhibited-like state bound to glucose-6-phosphate | |
7Q13 | P13807 | Human GYS1-GYG1 complex activated state bound to glucose-6-phosphate, uridine diphosphate, and glucose | |
7Q13 | P46976 | Human GYS1-GYG1 complex activated state bound to glucose-6-phosphate, uridine diphosphate, and glucose | |
7Q12 | P13807 | Human GYS1-GYG1 complex activated state bound to glucose-6-phosphate | |
7Q12 | P46976 | Human GYS1-GYG1 complex activated state bound to glucose-6-phosphate | |
4MQU | Q14397 | Human GKRP complexed to AMG-3969 and S6P | |
4LY9 | Q14397 | Human GKRP complexed to AMG-1694 [(2R)-1,1,1-trifluoro-2-{4-[(2S)-2-{[(3S)-3-methylmorpholin-4-yl]methyl}-4-(thiophen-2-ylsulfonyl)piperazin-1-yl]phenyl}propan-2-ol] and sorbitol-6-phosphate | |
4PX2 | Q14397 | Human GKRP bound to AMG2882 and Sorbitol-6-Phosphate | |
4MSU | Q14397 | Human GKRP bound to AMG-6861 and Sorbitol-6-phosphate | |
4MRO | Q14397 | Human GKRP bound to AMG-5980 and S6P | |
4OP3 | Q14397 | Human GKRP bound to AMG-5112 and Sorbitol-6-phosphate | |
4PX3 | Q14397 | Human GKRP bound to AMG-3295 and Sorbitol-6-phosphate | |
4OHP | Q14397 | Human GKRP bound to AMG-3227 and S6P | |
4OHO | Q14397 | Human GKRP bound to AMG-2668 | |
4OHK | Q14397 | Human GKRP bound to AMG-2526 and S6P | |
4OHM | Q14397 | Human GKRP bound to AMG-0771 and sorbitol-6-phosphate | |
4PX5 | Q14397 | Human GKRP bound to AMG-0696 and Sorbitol-6-phosphate | |
4PXS | Q14397 | Human GKRP bound to AMG-0265 (N-[(R)-(2-CHLOROPHENYL){7-[4-(2-HYDROXYPROPAN-2-YL) PYRIDIN-2-YL]-1-BENZOTHIOPHEN-2-YL}METHYL]CYCLOPROPANESULFONAMIDE) and Sorbitol-6-phosphate | |
4OLH | Q14397 | Human GKRP Bound to AMG5106 and Sorbitol-6-Phosphate | |
7KHD | Q9UNG2 | Human GITR-GITRL complex | |
7KHD | Q9Y5U5 | Human GITR-GITRL complex | |
6X3S | P47870 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with bicuculline methbromide | |
6X3S | 6X3S | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with bicuculline methbromide | |
6X3S | P47870 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with bicuculline methbromide | |
6X3S | 6X3S | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with bicuculline methbromide | |
6X3S | P14867 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with bicuculline methbromide | |
6X3S | P18507 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with bicuculline methbromide | |
6X3S | P18507 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with bicuculline methbromide | |
6X3T | P47870 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus propofol | |
6X3T | 6X3T | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus propofol | |
6X3T | P47870 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus propofol | |
6X3T | 6X3T | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus propofol | |
6X3T | P14867 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus propofol |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024